Posted On: 07/25/2016 11:55:03 AM
Post# of 1525
Progressive Care: PharmCo Receives State Licenses from New Jersey and Pennsylvania
MIAMI, FL -- July 25, 2016 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces the receipt of two new state licenses.
On July 21, 2016, the states of New Jersey and Pennsylvania granted non-resident pharmacy licenses to PharmCo, LLC. These licenses allow PharmCo to dispense traditional and compounded medications to the residents of these states from the Companys current facility. The Company is already conducting business in three other states: New York, Texas, and Florida.
We are excited to have the opportunity to service patients in New Jersey and Pennsylvania and continue to build the PharmCo brand, stated S. Parikh Mars, CEO. The Company has pending applications in numerous other states including Georgia and Illinios. We are looking forward to expanding our reach and delivering exceptional products and service to patients across the United States
Common Shares Issued and Outstanding:
As of July 14, 2016 the number shares of common stock issued and outstanding stood at 341,107,607 shares. This amount is net of the number of shares owned by PharmCo, LLC of 1,718,000.
MIAMI, FL -- July 25, 2016 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces the receipt of two new state licenses.
On July 21, 2016, the states of New Jersey and Pennsylvania granted non-resident pharmacy licenses to PharmCo, LLC. These licenses allow PharmCo to dispense traditional and compounded medications to the residents of these states from the Companys current facility. The Company is already conducting business in three other states: New York, Texas, and Florida.
We are excited to have the opportunity to service patients in New Jersey and Pennsylvania and continue to build the PharmCo brand, stated S. Parikh Mars, CEO. The Company has pending applications in numerous other states including Georgia and Illinios. We are looking forward to expanding our reach and delivering exceptional products and service to patients across the United States
Common Shares Issued and Outstanding:
As of July 14, 2016 the number shares of common stock issued and outstanding stood at 341,107,607 shares. This amount is net of the number of shares owned by PharmCo, LLC of 1,718,000.
(0)
(0)
